Emerging health isues in Asia and the Pacific: implications for public health policy
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Matthew Jowett & Anil Deolalikar & Peter Martinsson, 2004. "Health insurance and treatment seeking behaviour: evidence from a low‐income country," Health Economics, John Wiley & Sons, Ltd., vol. 13(9), pages 845-857, September.
- Easterly, William & Levine, Ross, 2003.
"Tropics, germs, and crops: how endowments influence economic development,"
Journal of Monetary Economics, Elsevier, vol. 50(1), pages 3-39, January.
- William Easterly & Ross Levine, 2002. "Tropics, Germs, and Crops: How Endowments Influence Economic Development," NBER Working Papers 9106, National Bureau of Economic Research, Inc.
- William Easterly & Ross Levine, 2002. "Tropics, Germs, and Crops: How Endowments Influence Economic Development," Working Papers 15, Center for Global Development.
- Philipson, Tomas, 2000.
"Economic epidemiology and infectious diseases,"
Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799,
Elsevier.
- Tomas Philipson, 1999. "Economic Epidemiology and Infectious Diseases," NBER Working Papers 7037, National Bureau of Economic Research, Inc.
- Finkelstein, Amy, 2004.
"The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program,"
Journal of Health Economics, Elsevier, vol. 23(1), pages 1-24, January.
- Amy Finkelstein, 2002. "The Interaction of Partial Public Insurance Programs and Residual Private Insurance Markets: Evidence from the U.S. Medicare Program," NBER Working Papers 9031, National Bureau of Economic Research, Inc.
- World Bank, 1992. "World Development Report 1992," World Bank Publications - Books, The World Bank Group, number 5975.
- Jack, William, 2000. "Health insurance reform in four Latin American countries : theory and practice," Policy Research Working Paper Series 2492, The World Bank.
- Shigeru Otsubo, 2002. "Working Paper 61 - Linking Africa to a Changing World," Working Paper Series 195, African Development Bank.
- Francis, Peter J., 1997. "Dynamic epidemiology and the market for vaccinations," Journal of Public Economics, Elsevier, vol. 63(3), pages 383-406, February.
- Cook, Ian G. & Dummer, Trevor J. B., 2004. "Changing health in China: re-evaluating the epidemiological transition model," Health Policy, Elsevier, vol. 67(3), pages 329-343, March.
- Wilson, Charles, 1977. "A model of insurance markets with incomplete information," Journal of Economic Theory, Elsevier, vol. 16(2), pages 167-207, December.
- Falkingham, Jane, 2004. "Poverty, out-of-pocket payments and access to health care: evidence from Tajikistan," Social Science & Medicine, Elsevier, vol. 58(2), pages 247-258, January.
- Brito, Dagobert L. & Sheshinski, Eytan & Intriligator, Michael D., 1991. "Externalities and compulsary vaccinations," Journal of Public Economics, Elsevier, vol. 45(1), pages 69-90, June.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Kelley Lee, 2014. "Health Policy in Asia and the Pacific: Navigating Local Needs and Global Challenges," Asia and the Pacific Policy Studies, Wiley Blackwell, vol. 1(1), pages 45-57, January.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
- Kessing, Sebastian G. & Nuscheler, Robert, 2006.
"Monopoly pricing with negative network effects: The case of vaccines,"
European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
- Kessing, Sebastian & Nuscheler, Robert, 2003. "Monopoly pricing with negative network effects: the case of vaccines [Monopolpreisbildung mit negativen Netzwerkeffekten am Beispiel von Impfstoffen]," Discussion Papers, Research Unit: Market Processes and Governance SP II 2003-06, WZB Berlin Social Science Center.
- Mark Gersovitz & Jeffrey S. Hammer, 2004.
"The Economical Control of Infectious Diseases,"
Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.
- Gersovitz, Mark & Hammer, Jeffrey S., 2001. "The economic control of infectious diseases," Policy Research Working Paper Series 2607, The World Bank.
- Rikard Forslid & Mathias Herzing, 2015.
"On the Optimal Production Capacity for Influenza Vaccine,"
Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
- Forslid, Rikard & Herzing, Mathias, 2008. "On the Optimal Production Capacity for Influenza Vaccine," CEPR Discussion Papers 6808, C.E.P.R. Discussion Papers.
- Stéphane Mechoulan, 2007.
"Market structure and communicable diseases,"
Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics, Canadian Economics Association, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2005. "Market Structure and Communicable Diseases," Working Papers tecipa-241, University of Toronto, Department of Economics.
- Luca Gori & Cristiana Mammana & Piero Manfredi & Elisabetta Michetti, 2022. "Economic development with deadly communicable diseases and public prevention," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 912-943, October.
- Proano, Ruben A. & Jacobson, Sheldon H. & Zhang, Wenbo, 2012. "Making combination vaccines more accessible to low-income countries: The antigen bundle pricing problem," Omega, Elsevier, vol. 40(1), pages 53-64, January.
- Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
- Thomas Wein, 2021. "Ist eine Impfpflicht gegen das Coronavirus nötig? [Is Mandatory Vaccination Against the Coronavirus Necessary?]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 101(2), pages 114-120, February.
- Raj Chetty & Amy Finkelstein, 2012.
"Social Insurance: Connecting Theory to Data,"
NBER Working Papers
18433, National Bureau of Economic Research, Inc.
- Chetty, Nadarajan & Finkelstein, Amy Nadya, 2013. "Social Insurance: Connecting Theory to Data," Scholarly Articles 34330197, Harvard University Department of Economics.
- Michael Kremer & Christopher M. Snyder, 2018.
"Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals,"
Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
- Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
- Goyal, Sanjeev & Vigier, Adrien, 2015.
"Interaction, protection and epidemics,"
Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
- Sanjeev Goyal & Adrien Vigier, 2014. "Interaction, Protection and Epidemics," Cambridge Working Papers in Economics 1458, Faculty of Economics, University of Cambridge.
- Barrett, Scott & Hoel, Michael, 2007.
"Optimal disease eradication,"
Environment and Development Economics, Cambridge University Press, vol. 12(5), pages 627-652, October.
- Michael Hoel & Scott Barrett, 2004. "Optimal Disease Eradication," Working Papers 2004.50, Fondazione Eni Enrico Mattei.
- Barrett, Scott & Hoel, Michael, 2009. "Optimal Disease Eradication," HERO Online Working Paper Series 2003:23, University of Oslo, Health Economics Research Programme.
- Finkelstein, Amy, 2004.
"The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program,"
Journal of Health Economics, Elsevier, vol. 23(1), pages 1-24, January.
- Amy Finkelstein, 2002. "The Interaction of Partial Public Insurance Programs and Residual Private Insurance Markets: Evidence from the U.S. Medicare Program," NBER Working Papers 9031, National Bureau of Economic Research, Inc.
- Philipson, Tomas, 2000.
"Economic epidemiology and infectious diseases,"
Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799,
Elsevier.
- Tomas Philipson, 1999. "Economic Epidemiology and Infectious Diseases," NBER Working Papers 7037, National Bureau of Economic Research, Inc.
- Andrea Sorensen, 2023. "The role of vaccine effectiveness on individual vaccination decisions and welfare," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 25(6), pages 1212-1228, December.
- Shosh Shahrabani & Amiram Gafni & Uri Ben-Zion, 2008. "Low Flu Shot Rates Puzzle—Some Plausible Behavioral Explanations," The American Economist, Sage Publications, vol. 52(1), pages 66-72, March.
- Jelnov, Artyom & Jelnov, Pavel, 2022.
"Vaccination policy and trust,"
Economic Modelling, Elsevier, vol. 108(C).
- Jelnov, Artyom & Jelnov, Pavel, 2021. "Vaccination Policy and Trust," GLO Discussion Paper Series 1003, Global Labor Organization (GLO).
- Jelnov, Artyom & Jelnov, Pavel, 2021. "Vaccination Policy and Trust," IZA Discussion Papers 14947, Institute of Labor Economics (IZA).
- Zachary S. Brown & Randall A. Kramer, 2018. "Preference Heterogeneity in the Structural Estimation of Efficient Pigovian Incentives for Insecticide Spraying to Reduce Malaria," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 70(1), pages 169-190, May.
- Toxvaerd, F. & Rowthorn, R., 2020. "On the Management of Population Immunity," Cambridge Working Papers in Economics 2080, Faculty of Economics, University of Cambridge.
More about this item
Keywords
mobidity; diseases; health insurance; social impact;All these keywords.
JEL classification:
- I10 - Health, Education, and Welfare - - Health - - - General
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:unt:jnapdj:v:12:y:2005:i:2:p:33-58. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Macroeconomic Policy and Development Division, ESCAP (email available below). General contact details of provider: https://edirc.repec.org/data/escapth.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.